Literature DB >> 28943076

Evidence-based Review on the Use of Proton Therapy in Lymphoma From the Particle Therapy Cooperative Group (PTCOG) Lymphoma Subcommittee.

Yolanda D Tseng1, David J Cutter2, John P Plastaras3, Rahul R Parikh4, Oren Cahlon5, Michael D Chuong6, Katerina Dedeckova7, Mohammad K Khan8, Shinn-Yn Lin9, Lisa A McGee10, Eric Yi-Liang Shen9, Stephanie A Terezakis11, Shahed N Badiyan12, Youlia M Kirova13, Richard T Hoppe14, Nancy P Mendenhall15, Mark Pankuch16, Stella Flampouri15, Umberto Ricardi17, Bradford S Hoppe18.   

Abstract

Entities:  

Mesh:

Year:  2017        PMID: 28943076     DOI: 10.1016/j.ijrobp.2017.05.004

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


× No keyword cloud information.
  21 in total

Review 1.  New Agents, Emerging Late Effects, and the Development of Precision Survivorship.

Authors:  Eric J Chow; Zoltan Antal; Louis S Constine; Rebecca Gardner; W Hamish Wallace; Brent R Weil; Jennifer M Yeh; Elizabeth Fox
Journal:  J Clin Oncol       Date:  2018-06-06       Impact factor: 44.544

2.  Proton therapy for adults with mediastinal lymphomas: the International Lymphoma Radiation Oncology Group guidelines.

Authors:  Bouthaina Shbib Dabaja; Bradford S Hoppe; John P Plastaras; Wayne Newhauser; Katerina Rosolova; Stella Flampouri; Radhe Mohan; N George Mikhaeel; Youlia Kirova; Lena Specht; Joachim Yahalom
Journal:  Blood       Date:  2018-08-14       Impact factor: 22.113

Review 3.  The impact of proton therapy on cardiotoxicity following radiation treatment.

Authors:  Andrew J Frankart; Rajaram Nagarajan; Luke Pater
Journal:  J Thromb Thrombolysis       Date:  2020-10-08       Impact factor: 2.300

4.  Irradiating Residual Disease to 30 Gy with Proton Therapy in Pediatric Mediastinal Hodgkin Lymphoma.

Authors:  Bradford S Hoppe; Raymond B Mailhot Vega; Nancy P Mendenhall; Eric S Sandler; William B Slayton; Howard Katzenstein; Michael J Joyce; Zuofeng Li; Stella Flampouri
Journal:  Int J Part Ther       Date:  2020-04-27

5.  Pencil beam scanning proton therapy of Hodgkin's lymphoma in deep inspiration breath-hold: A case series report.

Authors:  Karin M Andersson; Anneli Edvardsson; Annika Hall; Marika Enmark; Ingrid Kristensen
Journal:  Tech Innov Patient Support Radiat Oncol       Date:  2019-12-23

Review 6.  Cardiotoxicity of mediastinal radiotherapy.

Authors:  Ivica Ratosa; Maja Ivanetic Pantar
Journal:  Rep Pract Oncol Radiother       Date:  2019-10-30

7.  Rationale and early outcomes for the management of thymoma with proton therapy.

Authors:  He J Zhu; Bradford S Hoppe; Stella Flampouri; Debbie Louis; John Pirris; R Charles Nichols; Randal H Henderson; Catherine E Mercado
Journal:  Transl Lung Cancer Res       Date:  2018-04

8.  Association of Combined Modality Therapy vs Chemotherapy Alone With Overall Survival in Early-Stage Pediatric Hodgkin Lymphoma.

Authors:  Sachin R Jhawar; Zorimar Rivera-Núñez; Richard Drachtman; Peter D Cole; Bradford S Hoppe; Rahul R Parikh
Journal:  JAMA Oncol       Date:  2019-05-01       Impact factor: 31.777

9.  Consolidative proton therapy after chemotherapy for patients with Hodgkin lymphoma.

Authors:  B S Hoppe; C E Hill-Kayser; Y D Tseng; S Flampouri; H M Elmongy; O Cahlon; N P Mendenhall; A Maity; L A McGee; J P Plastaras
Journal:  Ann Oncol       Date:  2017-09-01       Impact factor: 32.976

10.  Clinical Intensity Modulated Proton Therapy for Hodgkin Lymphoma: Which Patients Benefit the Most?

Authors:  Georgios Ntentas; Katerina Dedeckova; Michal Andrlik; Marianne C Aznar; Ben George; Jiří Kubeš; Sarah C Darby; David J Cutter
Journal:  Pract Radiat Oncol       Date:  2019-01-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.